MedTrace Logo

TCM as an Adjuvant Treatment in Breast Cancer Patients

NCT04843865 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-12-31

No results posted yet for this study

Summary

Chinese herbs can alleviates the side effects caused by conventional treatment in breast cancer patients and affects the syndrome element differentiation by altering the specific set of proteomes at specific time point of treatment.

Conditions

Interventions

DIETARY_SUPPLEMENT

Chinese Herbs

Chinese Herbs

Sponsors & Collaborators

  • Universiti Tunku Abdul Rahman

    lead OTHER

Principal Investigators

  • Yang Mooi Lim · Universiti Tunku Abdul Rahman (UTAR)

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-22
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04843865 on ClinicalTrials.gov